Company A should typically include a best estimate of R&D reimbursements in the transaction price at the inception of the arrangement. Company A is also required to consider the constraint on variable consideration; however, since the related R&D services revenue would only be recognized as the costs are incurred, typically at no time would Company …
Читать далее «2024 Life Sciences Industry Accounting Guide Deloitte US»